Most people think of high blood pressure as a silent threat to the heart. But it’s time we start talking about another organ it quietly destroys: the kidneys.

As a public health researcher and clinician, I have seen how chronic kidney disease (CKD) creeps in unnoticed—especially among older adults—and how hypertension is often the unspoken culprit. Despite being preventable and treatable in its early stages, CKD remains a major cause of suffering and death, particularly in aging and underserved populations. And yet, it rarely gets the public attention it deserves.

In a recent analysis of data from the National Health and Nutrition Examination Survey (NHANES), I explored the relationship between hypertension and CKD in over 4,000 U.S. adults. What I found was alarming: Individuals with hypertension had a dramatically increased risk of developing CKD, and that risk grew even higher with age. For adults aged 60 and older, having high blood pressure nearly tripled the odds of CKD—even after controlling for other factors like race, income, diabetes, and medication use.

That is not just a clinical statistic—it is a wake-up call.

Why aren’t we catching this?

CKD often progresses in silence, with no obvious symptoms until it reaches an advanced stage. By then, patients may be facing dialysis, transplant lists, or devastating complications. If we are not actively looking for it—especially in patients with high blood pressure—we are missing a crucial window for prevention.

Current clinical practice tends to treat hypertension as a cardiovascular issue alone. But my research suggests we should be screening hypertensive patients more aggressively for early kidney damage, especially those in older age brackets. Routine testing for estimated glomerular filtration rate (eGFR) and urine albumin levels could uncover early signs of CKD, giving us a chance to intervene before irreversible damage occurs.

The age disparity

My findings also point to a sharp age-based disparity. While younger adults with hypertension were certainly at increased risk, the impact of high blood pressure on kidney function was significantly more pronounced in the older adult population. The combination of aging kidneys and elevated blood pressure appears to create a perfect storm.

This underscores a broader issue in preventive care: We often treat older patients reactively rather than proactively. But in the case of CKD, waiting for symptoms to appear is a costly mistake.

A call for policy and practice reform

We need to integrate kidney screening into standard hypertension management—especially in primary care settings serving vulnerable populations. Public health guidelines should promote targeted screening protocols, and insurers should cover routine eGFR and urine albumin tests for hypertensive adults over 60.

Additionally, community health programs could raise awareness about the link between hypertension and CKD, especially among at-risk groups such as Black, Hispanic, and low-income populations—who already face disproportionate burdens of both conditions.

From data to action

Public health research like mine is only as good as its impact. The numbers are clear, but change happens when clinicians, policymakers, and educators turn data into decisions. We cannot afford to ignore the silent progression of CKD in older adults—especially when one of its biggest risk factors, hypertension, is already in the exam room.

As a clinician-researcher, I believe in bridging the gap between academic data and patient care. Let us start by expanding the narrative around high blood pressure to include the kidneys. Let us normalize early kidney screenings for hypertensive patients. Let us give our aging patients a better shot at kidney health before it is too late.

Because silence is deadly—and in the case of CKD, it is time to speak up.

Edmond Kubi Appiah is a public health researcher and clinical research coordinator.